AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Coupa procurement pricing5/3/2023 Typically, companies spend tens to hundreds of millions of U.S. The cost of drug development is the full cost of bringing a new drug to market from drug discovery through clinical trials to approval. Tramontano explained the economic realities to me. Clinical Trial Supply Chains Must Be Reliable In short, I viewed this supply chain as much less important than the commercial supply chains that supply prescription and over the counter drugs. My supposition was that large inventories would be kept allowing for almost 100% service levels this would make the jobs of supply chain planners almost simple. Further, my impression is that the clinical trial supply chain would not be too concerned with costs. The smaller size should therefore make this supply chain much less costly, which would limit the savings that could be achieved through digital automation. The clinical trials supply chain would be much smaller. Tramontano gave me permission to cite him in this article, but he wanted to make it clear that all opinions expressed were his own. Until talking to Antonio Tramontano, the senior director of digital strategy in R&D clinical supply at Novartis, I had not realized how critical this supply chain was to pharmaceutical companies. If national drug agencies approve the drug, that drug can then be sold in that nation. Drug companies hold clinical trials to prove the safety and efficacy of their drugs. Then there is a clinical trials supply chain. There is the commercial supply chain where drugs that have been approved for use on patients are shipped to distributors, drug stores, and hospitals around the world. Pharmaceutical companies run two types of supply chains.
0 Comments
Read More
Leave a Reply. |